| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007707729 |
| P356 | DOI | 10.2165/00003088-200443030-00004 |
| P698 | PubMed publication ID | 14871157 |
| P50 | author | Lavern Vercaigne | Q40748256 |
| James Zacharias | Q56457405 | ||
| Robert E Ariano | Q56523862 | ||
| P2860 | cites work | Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies | Q31126712 |
| Application of a Bayesian method to monitor and adjust vancomycin dosage regimens | Q35261758 | ||
| Hemodialysis elimination rates and clearance of gentamicin and tobramycin | Q35756466 | ||
| Adverse antibiotic effects associated with renal insufficiency | Q37918336 | ||
| Aminoglycoside-induced hearing loss in humans | Q38676819 | ||
| Drug ototoxicity | Q39735584 | ||
| Vestibular toxicity of gentamicin. Incidence in patients receiving long-term hemodialysis therapy | Q40694970 | ||
| Histopathological findings in clinical gentamicin ototoxicity | Q42261847 | ||
| Ototoxicity of tobramycin in humans - influence of renal impairment | Q42261973 | ||
| The incidence of aminoglycoside antibiotic-induced hearing loss | Q44495198 | ||
| Pharmacokinetic population parameters for aminoglycosides in cholecystitis patients | Q46517598 | ||
| High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity | Q50538104 | ||
| Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. | Q50579015 | ||
| Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm. | Q52286139 | ||
| Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm. | Q52359286 | ||
| Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm. | Q52418226 | ||
| Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes. | Q53730047 | ||
| Aminoglycoside-induced ototoxicity | Q57810563 | ||
| Predicting serum gentamicin concentrations in patients undergoing hemodialysis | Q70058853 | ||
| Population pharmacokinetics: development of a medical intensive care unit-specific gentamicin dosing nomogram | Q70576417 | ||
| Prediction of serum gentamicin concentrations in patients undergoing hemodialysis | Q71286931 | ||
| Bobbing oscillopsia from gentamicin toxicity | Q72110441 | ||
| Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers | Q72717035 | ||
| Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers | Q72881706 | ||
| P433 | issue | 3 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| gentamicin | Q422482 | ||
| P304 | page(s) | 205-210 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Bayesian pharmacokinetics of gentamicin in a haemodialysis population | |
| P478 | volume | 43 |
| Q35531011 | Determination of vancomycin and gentamicin clearance in an in vitro, closed loop dialysis system. |
| Q51930719 | Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis. |
| Q35001792 | Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis |
| Q36666776 | Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing |
| Q81920817 | Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients |
Search more.